The global counterfeit pharmaceutical packaging market is estimated to reach USD 255.19 billion by 2028, growing at 12.58% CAGR during the forecast period from USD 44.01 billion in 2021.
The global counterfeit pharmaceutical packaging market is estimated to reach USD 255.19 billion by 2028, growing at a 12.58% CAGR during the forecast period from USD 44.01 billion in 2021. This report discusses market research on the counterfeit pharmaceutical packaging market, its growth factors, as well as its challenges. The report also mentions the opportunities available to potential investors in the anti-counterfeit pharmaceutical packaging market, discussing the recent changes due to COVID-19.
Fake medications, like counterfeit goods, are a global problem, with the largest fraud company in the world worth more than $260 billion per year. Anti-counterfeit pharmaceutical packaging has been introduced to the market as a result, thereby maintaining quality, originality, and security. These packages guarantee that the customer is buying authentic medical goods.
In 2016, the worldwide worth of counterfeit drugs was estimated to be between USD 70 and $260 billion, posing a serious threat to people's health all over the world. The rising markets, which are also major drug importers, are the ones that are most affected by this trade.
China, India, South Korea, Brazil, and Turkey have all adopted steps to improve the pharmaceutical industry's supplier safety. Silicon dioxide-based tags are used because they are generally recognized as safe (GRAS) and suitable for human consumption, according to US regulators.
The packing industry's supply lines were severely affected as the COVID-19 spread, leading to a shortage of basic materials such as plastics and labeling sheets. There's also a slight reduction in fast-moving consumer goods (FMCG) sales in the first quarter of 2020, as people were concerned about catching COVID from touching packaging materials. On the other hand, verification technology and packaging industries focused on resolving issues such as successfully communicating the benefits of anti-counterfeit wrapping in dealing with pandemic effects and ensuring the quality & safety of their product packaging while keeping a close eye on wellness programs and patient health safety.
Increased need for safe drugs to affect the global market positively
The rise of anti-counterfeit pharmaceutical packaging may be related to the increasing need for secure pharmaceutical medication packaging as a result of the expanding number of counterfeit products, which can compromise pharma businesses' reputations as well as patients' health. According to surveys, one out of every ten medical items sold in poor nations is fake or poor. The market for anti-counterfeit pharmaceutical packaging is expected to increase as more policies and regulations for anti-counterfeiting packaging are implemented to tamper evident or counterfeit packaged original and trademark medications.
High setup costs to restrain the global market growth
Anti-counterfeit packaging requires a high starting cost of development, which discourages the adoption of anti-counterfeit choices, reducing product demand. Furthermore, without proper customer awareness, many existing solutions are easy to replicate restricting business development.
Introduction of edible micro tags to boost market opportunities
A US-based business created a new technology called "micro tag" which is an edible packaging alternative used to identify, authenticate, protect brands, and ensure the purity of medications. Each tag has a unique identifier that can only be detected with the company's specialized equipment. The anti-counterfeit pharmaceutical packaging industry continues to benefit from technical improvements. Over the forecast period, all of these developments and innovations are expected to aid in the revolution of the global anti-counterfeit pharmaceutical packaging market.
The booming market for fake drugs and lack of information among customers pose a major threat
Customers' understanding of using these devices to assess an item's inventiveness is a challenge for anti-counterfeit packaging manufacturers. Customers need to be informed about technology so that counterfeit pharmaceutical product sales can be prevented. Developing these solutions costs a lot of money, putting pressure on the sector's growth.
|Historic Years||2016 - 2020|
|Forecast Years||2021 - 2028|
|Segments Covered||By Product Type, By Application, and By End Use|
|Forecast Units||Value (USD Billion), and Volume (Units)|
|Quantitative Units||Revenue in USD million/billion and CAGR from 2021 to 2028|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World|
|Countries Covered||U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others|
|Number of Companies Covered||10 companies with scope for including additional 15 companies upon request|
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.|
|Customization Scope||Avail customized purchase options to meet your exact research needs.|
The global anti-counterfeit pharmaceutical packaging market is segregated based on technology, application, and region. RFID, security inks or coatings, security visuals, holographic, mass encodings, and others are the segregation of the market depending on types of technology. The RFID industry is predicted to grow at a rapid pace as it is used in labeling data on medicinal products and also used to prevent the duplication of original objects.
Covert characteristics, overt characteristics, forensic signs, tamper-proof, track & trace techniques, and others are the applications of anti-counterfeit pharmaceutical packaging. The track & trace techniques sector will retain a larger part of the market given its technological advancements and application, such as tracking down objects to determine their locations.
North America to lead the global market in the forecast period
North America is the world's greatest pharmaceutical and biologics research hub, exporting biopharmaceutical goods to all corners of the globe. Additionally, firms are investing heavily in exploration, which is expected to drive the anti-counterfeit pharmaceutical packaging market in the region forward.
The surge is attributed to strict anti-counterfeiting legislation, with new drugs requiring a statewide tracking system for all prescription medications. Moreover, the United States' leadership in the global anti-counterfeit pharmaceutical packaging market might be ascribed to notable producers' rising demand for innovative and pricey technology such as RFID.
In the United States, regulatory agencies have adopted regulations requiring identification and transparency as fundamental ways to ensure the protection of public health and reduce risk, which is fueling the need for anti-counterfeit pharmaceutical packaging. On an identical basis, Europe is ranked second. Belgium, Denmark, and Germany are the major European countries to lead the anti-counterfeit pharmaceutical packaging industry. With improvements in the healthcare system, Asia Pacific is likely to gain traction in the anti-counterfeit pharmaceutical packaging industry.
Some drug manufacturers have created teams whose sole purpose is to protect their trademark against counterfeiting and illegal duplication, resulting in an increase in the need for anti-counterfeit pharmaceutical packaging. All of these issues contribute to a rise in the need for anti-counterfeit pharmaceutical packaging where the following companies are playing a major role in the market:
Counterfeits or making duplicate devices are illicit reproductions of a trademarked brand which are identical to genuine products. Those counterfeit goods contain clothing, medications and pharmaceutical products, electronics, and jewelry among others. In order to counter infringement, secure packaging is necessary. Secure and safe packaging in case of medicinal and other pharmaceutical products is one of the crucial techniques to keep these products away from counterfeiting. Anti-counterfeit packaging is the next level or method of secure packaging to the product in order to diminish infringement. In the process of anti-counterfeit packaging, secure packaging is implemented that prevents duplication and assures the safety and security of the medicinal goods. Anti-counterfeit measurements are adopted by organizations with the collaboration of government in developed as well as developing nations, in order to counterfeit not only in terms of goods and products but also in terms of revenue and brand value loyalty.
Anti-counterfeit pharmaceutical packaging is experiencing the highest growth rate for waste streams in developed as well as developing countries. Rising health awareness among the people across the globe is the main factor that is fueling the growth of the market. Medicinal and pharmaceutical products are regarded as one of the basic needs of consumer whenever they are facing some serious health issue. According to OECD (Organization for Economic Co-operation and Development), about 10% of the pharmaceutical products are counterfeit. This imitation or duplication of medical products happens in the supply chain or distribution of any organization. For this reason, the counterfeiting of the products is very difficult to counter and regulate. In addition, duplicate medicines affect the reputation of the pharmaceutical organizations along with the patient's health. Thus, organizations across the globe are adopting various technologies in order to counter the infringement of the medicinal devices. In order to retain the brand loyalty and brand image in the minds of consumers, organizations are heavily investing in R&D activities in order to come up with the secure packaging of pharmaceutical products. Such factors are contributing towards the market growth and development during the forecast time period.
Based on the usage, the anti-counterfeit pharmaceutical packaging market is categorized into covert features, forensic markers, overt features, tamper evidence, track & trace technologies. Trace and track technologies can be bifurcated into serialization and identification. On the basis of technology, the market is segmented into RFID, security printing and graphics, security ink coatings, mass encoding, and holograms. RFID is divided into active tags, semi-active tags, and passive tags. Mass encoding can further be segmented into barcode application, digital mass encryption, and others (electronic surveillance technologies).
North America held noteworthy revenue share of the global anti-counterfeit pharmaceutical packaging market in 2017 and the region is expected to continue with its regional superiority over the forecast period. The growth of this regional market is attributed because of the stringent regulations formulated by the government coupled with FDA. In addition, the region is the major biologics research hub, which exports medical and pharmaceutical products across the globe. Such factors are contributing to the growth of the market in the region. The Asia Pacific is predicted to provide significant opportunities for anti-counterfeit pharmaceutical packaging. The growth of the region is anticipated due to raising awareness among the consumers and manufacturers regarding infringement. Moreover, the rising trend towards social and healthcare system in the regions is fueling the growth of the market. Such factors are expected to drive anti-counterfeit pharmaceutical packaging market growth in the Asia Pacific region over the forecast timeframe.
Some of the industry players operating in the anti-counterfeit pharmaceutical packaging market include Zebra Technologies Corporation, Dennison Corporation, E.I. du Pont de Nemours and Company, AlpVision SA, Sicpa Holding SA, Applied DNA Sciences Inc., Amcor Limited, Authentix Inc., CCL Industries Inc., and Atlantic Zeiser GmbH.
The rise of anti-counterfeit pharmaceutical packaging may be related to the increasing need for secure pharmaceutical medication packaging as a result of the expanding number of counterfeit products, which can compromise pharma businesses' reputations as well as patients' health. The market for anti-counterfeit pharmaceutical packaging is expected to increase as more policies and regulations for anti-counterfeiting packaging are implemented to tamper evident or counterfeit packaged original and trademark medications.
As per Zion Market Research, the global anti-counterfeit pharmaceutical packaging market is estimated to reach USD 255.19 billion by 2028, growing at a 12.58% CAGR during the forecast period from USD 44.01 billion in 2021.
North America to lead the global market in the forecast period. North America is the world's greatest pharmaceutical and biologics research hub, exporting biopharmaceutical goods to all corners of the globe. Additionally, firms are investing heavily in exploration, which is expected to drive the anti-counterfeit pharmaceutical packaging market in the region forward.
Alien Technology Corp., TraceLink Inc., Alpvision, Zebra Technologies, Avery Dennison, Inksure Technologies, Flint Group, Catalent Pharma Solution Inc., and Sicapa are some key players in the global anti-counterfeit pharmaceutical packaging market.